Skip to content
ALECAlector, Inc.

Earnings

When Alector, Inc. reports, what it reported each quarter, and how the stock took the results.

35 quarters. Mar 31, 2018 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 24, after the close

Wed, Feb 24, 2027in 99 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 22 – Mar 26

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$6.24M
Revenue, change from a year earlier: Q3 2026 +4,895.9%, Q2 2026 −57.8%, Q1 2026 −71.5%, Q4 2025 −88.5%
Net income
-$37.27M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$162.87M+4,895.9% vs Q3 2025

Latest results

  1. Q3 2026Nov 5, 2026, after the closeThe release+10.1%by the close of Nov 6
    Revenue
    $162.87M
    +4,895.9%
    Net income
    $124.60M
    N/M
    EPS
    $1.11
    N/M
    Entered exclusive global license agreement with Genentech for AL050, Alector's brain-penetrant GCase enzyme replacement therapy (ERT), including a $100 million upfront payment and eligibility for up to $1.17 billion in milestone payments plus tiered royalties on net sales.
  2. Q2 2026Aug 6, 2026, after the closeThe release4.3%by the close of Aug 7
    Revenue
    $3.32M
    −57.8%
    Net income
    -$22.99M
    N/M
    EPS
    -$0.21
    N/M
  3. Q1 2026May 7, 2026, after the closeThe release13.7%by the close of May 8
    Revenue
    $1.05M
    −71.5%
    Net income
    -$22.93M
    N/M
    EPS
    -$0.21
    N/M
  4. Q4 2025Feb 25, 2026, after the closeThe release+6.7%by the close of Feb 26
    Revenue
    $6.24M
    −88.5%
    Net income
    -$37.27M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · after-hoursNov 5, 202636 d10-Q$162.87M+4,895.9%$1.11+10.1%
Q2 2026Jun 30, 2026Aug 6, 2026 · after-hoursAug 6, 202637 d10-Q$3.32M−57.8%-$0.214.3%
Q1 2026Mar 31, 2026May 7, 2026 · after-hoursMay 7, 202637 d10-Q$1.05M−71.5%-$0.2113.7%
FY 2025
Q4 2025derivedDec 31, 2025Feb 25, 2026 · after-hoursFeb 25, 202656 d10-K$6.24M−88.5%—+6.7%
Q3 2025Sep 30, 2025Nov 6, 2025 · after-hoursNov 6, 202537 d10-Q$3.26M−78.8%-$0.342.3%
Q2 2025Jun 30, 2025Aug 7, 2025 · after-hoursAug 7, 202538 d10-Q$7.87M−47.8%-$0.30+48.3%
Q1 2025Mar 31, 2025May 8, 2025 · after-hoursMay 8, 202538 d10-Q$3.67M−76.9%-$0.41+14.0%
FY 2024
Q4 2024derivedDec 31, 2024Feb 26, 2025 · after-hoursFeb 26, 202557 d10-K$54.24M+257.1%—3.8%
Q3 2024Sep 30, 2024Nov 6, 2024 · after-hoursNov 6, 202437 d10-Q$15.34M+68.4%-$0.43+7.6%
Q2 2024Jun 30, 2024Aug 7, 2024 · after-hoursAug 7, 202438 d10-Q$15.08M−73.2%-$0.40—
Q1 2024Mar 31, 2024May 8, 2024 · after-hoursMay 8, 202438 d10-Q$15.89M−4.0%-$0.38—
Earlier years, FY 2018 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026449871
10-QAug 6, 2026338052
10-QMay 7, 2026211981
10-KFeb 25, 2026071593
10-QNov 6, 2025269592
10-QAug 7, 2025105050
10-QMay 8, 2025066987
10-KFeb 26, 2025027758
10-QNov 6, 2024122328
10-QAug 7, 2024092814

Provenance

ProvenanceData status and checks

Alector, Inc. · CIK 1653087 · Engraved from SEC EDGAR